FIELD: medicine.
SUBSTANCE: present group of inventions refers to medicine, namely to therapy and cardiology, and concerns lowering triglycerides without increasing LDL cholesterol in an individual receiving a concomitant statin therapy with initial fasting triglycerides 200 mg/dl to 500 mg/dl. That is ensured by administering ethyl eicosapentaenoate 4 g a day additionally.
EFFECT: invention provides lowering both total triglycerides, and low-density lipoproteins.
30 cl, 6 tbl
